Ibritumomab
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Inspired by his work with antiserum to prevent and treat infectious disease, Paul Ehrlich (see figure) envisioned a day when…
TheTranslational ResearchWorkingGroup (TRWG)was created as a national initiative to evaluate the current status of the investment…
Targeted immunotherapy utilizing monoclonal antibodies has improved survival in both indolent and aggressive lymphoma…
A great deal of interest has surrounded the use of monoclonal antibodies (mAbs) and mAb-based regimens for cancer therapy…
In recent years monoclonal antibodies have played an important role in cancer therapy. This successful track is grosso modo based…
Ibritumomab, an (90)Yttrium ((90)Y) labelled radioimmunoconjugate, is registered in Europe to treat follicular lymphomas. Its…
The concept of targeted therapy for patients with advanced cancer has intrigued researchers for many years. The lymphoid…